Gene therapy for hemophilia, a clinical viewpoint
Gene therapy for hemophilia has been investigated for decades but no breakthroughs were made until Nathwani et al.achieved a significant and sustainable factor IX increase in hemophilia B patients in 2011.About eleven years later, in August 2022, the first hemophilia A gene therapy product was approved by the European Commission and hemophilia trea